Reasons To Buy, Hold And Sell Aviva plc

Here’s why investors have differing opinions on Aviva plc (LON: AV).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Aviva (LSE: AV) (NYSE: AV.US) is one of the larger companies in the FTSE 100, and many private investors have differing opinions on the insurers and its prospects.

So here’s a quick rundown of the key reasons why you may wish to buy, sell or simply hold on to the company’s stock.

Buy

The main reason to buy Aviva is that it looks pretty cheap right now. At 384p per share at the time of writing, it stands at a 13% discount to its latest published net asset value (which was 441p as at 30 June 2013, as calculated on the industry-standard Market Consistent Embedded Value basis).

If P/E ratios are more your thing, although they are arguably less useful when analysing insurance companies, Aviva compares pretty well with its closest rivals. Aviva trades on a forward P/E of  9 times for 2013, whereas the likes of RSA (LSE: RSA) and Legal & General (LSE: LGEN) trade on 10 and 12 respectively.

You could also argue Aviva shares are due a good run. They are down 25% over the last decade, whereas RSA is up around 25% and Legal & General about 75%. So, if you believe in reversion to the mean, there could be a catch up opportunity here.

Hold

Aviva is in a state of transition at the moment, although  I could have said that same statement at pretty much any time during the last decade.

The last couple of years have been spent shedding unwanted parts of its business with less impressive market positions. Aviva has classified its divisions as red, amber and green, and as at March 2013 reported 9 red cells, 20 amber cells and 22 green cells. Progress has been made, but there’s obviously more work to do.

The insurer is also under new management, in the form of Mark Wilson, who only took up the CEO post at the start of 2013. The performance of the company since that time has been pretty good, although there were a number of one-off factors in the recent set of half-year results that may have flattered to deceive. It’s early days for Mark Wilson, and it takes time to turn around a ship the size of Aviva.

Sell

Aviva now has a bit of a reputation as a serial disappointer. To awkwardly paraphrase Oscar Wilde… to cut your dividend once may be regarded as a misfortune; to cut it twice looks like carelessness. Aviva has reduced its dividend twice since 2008. Whereas it paid out 23p per share in 2003, the total for 2013 is likely to be 15-16p.

I also came across a recent article in the insurance journal Post Online with the unsettling headline of “Insiders fear Aviva is ‘falling apart'”. It covers, in quite some detail, a number of high-level departures at the company. Such situations are always hard for outsiders to judge. When a company gets new management, churn at the top is common, but it’s difficult to know whether this represents a necessary fresh start or wider dissatisfaction.

What now?

If you are looking for blue chips that boast quibble-free ‘buy’ cases, then this exclusive wealth report reviews five blue-chip names that could genuinely benefit YOUR portfolio.

In fact, all five selections offer a mix of robust prospects, illustrious histories and dependable dividends, and have just been declared by the Fool as “5 Shares You Can Retire On“.

Just click here for this special report now — it’s free for a limited time only.

> Stuart does not own any share mentioned in this article.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »